Apronal
Apronal is a barbiturate derivative that was developed in the early 20th century. It is known for its sedative and hypnotic properties, which make it useful in the treatment of insomnia and other sleep disorders. Apronal is chemically related to other barbiturates such as phenobarbital and secobarbital.
Chemical Structure and Properties[edit]
Apronal, also known as apronalide, has the chemical formula C10H12N2O3. It is a white, crystalline powder that is soluble in water and alcohol. The compound is typically administered orally in the form of tablets or capsules.
Pharmacology[edit]
Apronal works by enhancing the activity of the gamma-aminobutyric acid (GABA) neurotransmitter in the central nervous system (CNS). This action results in a calming effect on the brain, which helps to induce sleep and reduce anxiety. Like other barbiturates, apronal can be habit-forming and has a potential for abuse.
Medical Uses[edit]
Apronal is primarily used for the short-term treatment of insomnia. It may also be prescribed for its anxiolytic effects to help manage anxiety disorders. Due to its potential for dependence and the availability of safer alternatives, the use of apronal has declined in recent years.
Side Effects[edit]
Common side effects of apronal include drowsiness, dizziness, and headache. More serious side effects can include respiratory depression, hypotension, and allergic reactions. Long-term use can lead to tolerance, dependence, and withdrawal symptoms.
History[edit]
Apronal was first synthesized in the early 20th century and was widely used as a sedative and hypnotic agent. However, with the development of newer, safer medications such as benzodiazepines and non-benzodiazepine sleep aids, the use of apronal has significantly decreased.
Regulation[edit]
Due to its potential for abuse and dependence, apronal is classified as a controlled substance in many countries. Its use is strictly regulated, and it is generally only available by prescription.
See Also[edit]
References[edit]
External Links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
